Compare Invesco Preferred ETF (PGX) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Preferred ETF vs 22nd Century Group Inc — how do they compare? Invesco Preferred ETF trades at $10 (market cap $3.60B), while 22nd Century Group Inc trades at $0.84 (market cap $621.67K). The key difference: Invesco Preferred ETF is far larger — about 5790.9× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 5,986,026). Which is the better fit depends on your goals — on Pluang, investors hold Invesco Preferred ETF for 94 Days and 22nd Century Group Inc for 32 Days on average.
| PGX | XXII | |
|---|---|---|
Market Cap | $3.60B | $621.67K |
Volume | 5,986,026 | 45,625 |
52-Week High | $11.61 | $483.00 |
52-Week Low | $9.97 | $0.80 |
Typical Hold Time | 94 Days | 32 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PGX trades at $10.005, up 0.35% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock lacks disclosed financial ratios such as P/E and P/S, and no recent income statement or cash flow data is available. Recent corporate actions include dividend payments scheduled for 2026, but current fundamental metrics are not provided.
The outlook for PGX is cautious due to the absence of current financial data and bearish technical signals. Investment opportunities hinge on future earnings visibility and valuation clarity, while risks include potential earnings volatility and market sentiment shifts. Investors should await updated financial disclosures for a clearer assessment.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
